Yahav Achim Ve Achayot Provident Funds Management Co Ltd. Invests $1.33 Million in SPDR S&P Biotech ETF $XBI

Yahav Achim Ve Achayot Provident Funds Management Co Ltd. bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 10,867 shares of the exchange traded fund’s stock, valued at approximately $1,325,000. SPDR S&P Biotech ETF accounts for approximately 3.0% of Yahav Achim Ve Achayot Provident Funds Management Co Ltd.’s portfolio, making the stock its 13th largest holding.

Several other large investors have also recently modified their holdings of the business. JPMorgan Chase & Co. increased its stake in shares of SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of SPDR S&P Biotech ETF by 13.5% in the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after purchasing an additional 220,244 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of SPDR S&P Biotech ETF by 40.5% in the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after purchasing an additional 353,351 shares in the last quarter. LPL Financial LLC increased its stake in shares of SPDR S&P Biotech ETF by 27.0% in the fourth quarter. LPL Financial LLC now owns 875,547 shares of the exchange traded fund’s stock worth $106,755,000 after purchasing an additional 185,964 shares in the last quarter. Finally, Greenhouse Funds LLLP increased its stake in shares of SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after purchasing an additional 96,308 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 3.0%

Shares of NYSEARCA:XBI opened at $132.74 on Friday. The company has a 50 day moving average of $132.53 and a 200 day moving average of $127.08. The stock has a market cap of $8.47 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.